Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2011 , Vol 53 , Num 3
MATRIX DOSAGE FORM OF DILTIAZEM HYDROCHLORIDE: DEVELOPMENT, CHARACTERIZATION AND IN VITRO EVALUATION
SUBHASH S VAGHANİ, MANİSH GOYANİ, SUDARSHAN SİNGH
Smt. R. B. Patel Mahila Pharmacy College, Atkot, Gujarat, India

Summary

Istanbul Medipol University